Direktorat Registrasi ObatValid

CETIRIZINE DIHYDROCHLORIDE

Claim this product
BPOM Number
GKL1912526437A1
Approved
21 November 2024
Expiry
15 February 2026
Form
SIRUP; 5 MG

About This Registration

CETIRIZINE DIHYDROCHLORIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1912526437A1. Its current registration status is Valid, with the licence valid until 15 February 2026. The product is registered to KIMIA FARMA TBK. - INDONESIA. BPOM first approved this registration in February 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 BOTOL @ 60 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

CETIRIZINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
KIMIA FARMA TBK. - INDONESIA holds 355 BPOM registrations
Manufacturer Scale
KIMIA FARMA TBK. - INDONESIA produces 355 registered products
Registration Age
Registered for 5 years, 7 months
Expiry Status
Expired 224 days ago

FDA Cross-Reference

via openFDA
Generic Name
CETIRIZINE HYDROCHLORIDE
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
Purpose Antihistamine

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from KIMIA FARMA TBK. - INDONESIA

KIFAROX

-DKL2644412109A1
Valid
Approved: Apr 24, 2026KAPLET SALUT SELAPUT
View product →

CIPROFLOXACIN HYDROCHLORIDE

-GKL2644412209A1
Valid
Approved: Apr 24, 2026KAPLET SALUT SELAPUT
View product →

RESQUILINE

-DKI2571000110A1
Valid
Approved: Dec 10, 2025TABLET
View product →

GLIMEPIRIDE

-GKL2544412010A1
Valid
Approved: Nov 12, 2025TABLET
View product →

ACETYLSALICYLIC ACID

-GKL2544411915A1
Valid
Approved: Nov 10, 2025TABLET SALUT ENTERIK
View product →

Products in the same class

PREGAPAIN

-DKL2402366801B1
Valid
Approved: Apr 16, 2026KAPSUL
BERNOFARM - INDONESIA
View product →

DEXKETOPROFEN TROMETAMOL

-GKL2043004343A1
Valid
Approved: Mar 26, 2026INJEKSI
NULAB PHARMACEUTICAL INDONESIA - INDONESIA
View product →

ETABROXOL

-DKL1906510436A1
Valid
Approved: Feb 2, 2026DROPS
ERRITA PHARMA
View product →

VIOQUIN

-DKL0435300709A1
Valid
Approved: Nov 23, 2025KAPLET SALUT SELAPUT
GRACIA PHARMINDO
View product →

CLONATE

-DKL2010811229A1
Valid
Approved: Nov 23, 2025KRIM
BERLICO MULIA FARMA - INDONESIA
View product →
1